16
Participants
Start Date
October 1, 2022
Primary Completion Date
September 1, 2024
Study Completion Date
September 1, 2024
TP1
Participants will be administered TP1 during one of the experimental visits.
TP2
Participants will be administered TP2 during one of the experimental visits.
Placebo
Participants will be administered placebo during one of the experimental visits.
RECRUITING
The University of Memphis, Memphis
University of Memphis
OTHER
Liquid I.V.
OTHER